Anti-Obesity Medication Policy

We have started receiving enquiries from patients regarding the prescription of weight loss medication, specifically Tirzepatide (Mounjaro), which was approved by NICE for use on the NHS at the end of December 2024.

All GPs in Bristol, North Somerset & South Gloucestershire (BNSSG) have been told not to prescribe this medication for weight loss at this time whilst the local system decides how this will be best implemented. There will be strict eligibility criteria for access. Therefore, please do not contact the practice with enquiries regarding this. Any patient that does contact the practice will be directed to this statement. BNSSG have created some FAQs for further information which can be accessed here - https://remedy.bnssg.icb.nhs.uk/media/2racg235/faqs-tirzepatide-patients-april-25-update-final.pdf